← Eichor
Study identifier: NCT04904757 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening

Condition: Mammographic Breast Density · Mammography  ·  Sponsor: University of Virginia

PhaseNA
Planned participants210
Who can joinFemale, 40 Years to 69 Years
Healthy volunteersYes

About this study

The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.

This description comes directly from the study's public registry record.

Talk to the study team

Kathy L Repich, RN  ·  4342434540  ·  klr3b@virginia.edu

Matthew M Miller, MD  ·  MM5CA@hscmail.mcc.virginia.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UVA Breast Care CenterCharlottesville, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04904757